MannKind Corp 2022 SR
The report highlights MannKind's 2022 ESG progress, focusing on its mission to address unmet medical needs in endocrine and orphan lung diseases. Key achievements include launching the Coaching Connections performance program, achieving a 66% female representation in management, and reducing exterior electricity usage by 50% at the Danbury facility through LED conversion. The company also implemented a new reverse osmosis system to reduce wastewater discharge by 100,000 gallons annually and recovered 130,000 lbs of waste via trash-to-energy processes. Governance remains strong with an 89% independent board and a commitment to ethical conduct and data privacy.
Company: MannKind Corp
Sector: Health Care
Country: United States
Year: 2022
Type: SR
Pages: 41
Back to company
MannKind Corp
ESG Report
The report highlights MannKind's 2022 ESG progress, focusing on its mission to address unmet medical needs in endocrine and orphan lung diseases. Key achievements include launching the Coaching Connections performance program, achieving a 66% female representation in management, and reducing exterior electricity usage by 50% at the Danbury facility through LED conversion. The company also implemented a new reverse osmosis system to reduce wastewater discharge by 100,000 gallons annually and recovered 130,000 lbs of waste via trash-to-energy processes. Governance remains strong with an 89% independent board and a commitment to ethical conduct and data privacy.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees